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Intracerebral (i.c.) 1 infection of mice with many isolates of lymphocytic chori- 
omeningitis (LCM) virus (LCMV) causes in most mice a severe lethal choriomen- 
ingitis. The pathogenesis of this disease has been carefully studied for many years 
(1-5).  Most investigators agree that T  cells are  crucially involved (1-7);  some 
(7-10)  argue in favor of cytotoxic T  cells restricted to the major histocompati- 
bility gene complex (MHC) class I antigens (H-2K and -D in mice) whereas others 
(11-14)  interpret results to suggest that T  cells involved in delayed-type hyper- 
sensitivity may be more instrumental. Since T  cells that are restricted to H-2D 
class I but not class II H-2 antigens have been shown to adoptively transfer LCM- 
disease (8) as well as a primary type of footpad swelling reaction (15,  16) the two 
notions are not unreconcilable. In addition, it has been shown (i 7-19) in model 
situations in vitro that cytotoxic MHC class I-restricted T  cells, as well as class 
II-restricted T  cells, release a variety of soluble factors, e.g. interleukins, which 
may well trigger the delayed-type hypersensitivity like cellular infiltrates found 
in footpads or in leptomeninges. 
We have compared two LCMV isolates, Docile (D) and Aggressive (A), (4, 20, 
21) in a  preliminary report (22),  and present here more detailed experiments. 
The  two  LCMV  isolates  (4,  20,  22)  caused  either  lethal  LCM  or  no  obvious 
disease, dependent upon the mouse strain tested. In all examples studied here, 
early and high cytotoxic T  cell responses correlated with early and high primary 
footpad swelling reactions, and both directly correlated with great susceptibility 
to LCM disease. All three parameters were found to be predominantly regulated 
by the H-2D region. 
This work was supported by grant 3.323-0.82 from the Swiss National Science Foundation, and in 
part by grant AI-17285 from the National Institute of Allergy and Infectious Diseases, Bethesda, 
MD, and by the Kanton of Zurich. 
i Abbreviations used in this paper:  A, aggressive strain of LCMV; D, docile strain of LCMV; i.c., 
intracerebral; i.f., in footpad; i.v., intravenous; LCM, lymphocytic  choriomeningitis; LCMV, LCM 
virus; LU, lytic  unit; MHC, major histocompatibility  complex; NK, natural killer; pfu, plaque-forming 
unit. 
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Materials and  Methods 
Lymphocytic Choriomeningitis Virus.  LCMV-A and  LCMV-D of known concentration 
(measured in plaque-forming units [pfu]) were obtained directly from C.  Pfau (14,  20, 
21),  Rensselaer Polytechnical Institute, Troy, NY.  Stocks were diluted in medium con- 
taining 5% heat-inactivated fetal calf serum. 
Mice.  Mice were purchased from the Institute ffir Zuchthygiene, Abteilung Labortier- 
kunde,  Tierspital,  Zfirich  (ICR,  C57BL/6,  BALB/c,  DBA/2,  C57BL/10,  B10.BR, 
B10.D2,  A/J,  CBA/J,  C3H/HeJ, and  BALB.K), from OLAC,  Bicester, Oxon,  United 
Kingdom  (B10.G,  AKR,  A2G,  DBA/1,  D2.GD),  from  The Jackson  Laboratory,  Bar 
Harbor,  ME  (B10.MBR),  from  Bantin-Kingman,  Aldbrough,  Hull,  United  Kingdom 
(SWR/J),  or  from  Iffa-Credo, St.  Germain-sur  l'Arbresle,  France  (D2.GD,  BALB.G, 
DBA/1,  DBA/2). Some mice were a  gift from the  Institut ffir Biologisch-Medizinische 
Forschung AG, F/illinsdorf, Switzerland (C3H.Q), or the Basel Institute of Immunology, 
Basel, Switzerland (B6.AK 1, B 10.MBR).  Mice of either sex were used at 8-20 wk of age. 
Routes of Infection.  Mice were injected either i.c. or into the footpad (i.f.) with 30 tal, 
or intravenously (i.v.) with 0.2 ml of a virus dilution containing usually ~500-1,000 pfu 
of LCMV, unless stated otherwise. 
Media.  Minimal  essential  medium  was  supplemented  with  5-10%  heat-inactivated 
fetal  calf serum,  glutamine,  bicarbonate,  penicillin, and  streptomycin.  All  ingredients 
were from KC-Biologicals,  Lenexa, KS. 
Cytotoxicity Assays.  Activity of cytotoxic T  cells was tested in 5~Cr-release assays (4, 23, 
24).  Target ceils were established fibrosarcoma cell lines:  MC57G (H-2b), Q  (H-2q), D2 
(H-2a). The test was performed in round-bottomed 96-well plates. Effector cells and target 
ceils (104) were each added in 100 #1 to give effector/target cell ratios of 40:1, 13:1,  4:1. 
They were mixed well and spun at ~1,000 g for 4 min. The test duration was usually 5 
h. Spontaneous ~lCr  release is indicated in the Tables and Figures. To assess cytotoxic 
activity semiquantitatively,  lytic units  (LU)  were  determined according to  established 
procedures (23) from dose-response curves; one LU represents the average number of 
spleen cells or meningeal infiltrate cells that lyse 33% of the target cells in a standard test 
well during the given test duration. 
Meningeal Infiltrate Cells.  The procedure used to obtain meningeal infiltrate cells has 
been described in detail previously (7,  8, 21, 25).  Briefly, mice were ether-anesthetized 
and bled. The cerebrospinal fluid was tapped through the tectum of the fourth ventricle 
after careful preparation of the area. The skull cap was cut off, the brain and the skull 
were extensively rinsed with cold medium. 
Primary Footpad Assay.  Footpad swelling after local infection with LCMV (26, 27) was 
measured with a spring-loaded caliper (Kr6plein, Schluchtern, Hessen, Federal Republic 
of Germany). 
Results 
Comparison  of Various Methods for In Vivo Titration of LCMV-A vs. -D.  Various 
doses  of LCMV-A  or -D  (measured  as  pfu)  were  injected  i.c.  or  i.f.  into  ICR 
outbred mice (Fig.  1).  Mortality by day  12  caused by LCMV-A vs. -D injected 
i.c. was registered, and increase in footpad thickness 7 and 8 d after infection i.f. 
were assessed.  The LDs0 for LCMV-A was ~2 pfu, whereas for LCMV-D it was 
~0.2 pfu, confirming previous results by Pfau et al.  (21).  Footpad swelling was 
observed with  ~3  pfu  for LCMV-A,  vs.  ~1  pfu  for LCMV-D.  The  mice that 
survived the i.c. infection were injected again on day 21  after primary infection 
with  LCMV-Armstrong  to determine whether protective immunity had  devel- 
oped. The mice that had been infected originally with ~1  pfu of LCMV-A or -D 
survived the  second challenge.  The  50%  protective dose (PDs0) could be  esti- 
mated  at  -0.3  pfu  for LCMV-A  and  ~0.2  pfu  for LCMV-D.  Thus,  the  LDs0 
defined by mortality differed between A and D by a factor of 10-30 (as confirmed ZINKERNAGEL  ET  AL.  2127 
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FIGURE 2.  Mortality of various strains of mice injected i.c. with various doses (pfu) of LCMV- 
A (0) or -D (0)- 
also in two additional experiments). The doses needed to cause primary footpad 
swelling or to induce protective immunity  in  50%  of infected mice were quite 
comparable, and corresponded well with pfu titers. 
Mortality Assessed  in  Various Mouse Strains.  The  susceptibility to  LCMV-A- 
and  -D-induced  lethal  disease varied considerably,  dependent  upon the  mouse 
strains tested (Fig. 2). Percentage of mortality was comparable over a wide dose 
range in most strains (SWR/J, ICR, C57BL/6, A/J), but varied considerably in 
C3H/HeJ  mice.  Susceptibility  to  LCMV-induced  lethal  disease  declined  with 
doses  of <_1  pfu  for  LCMV-A  or  -D  in  most  strains.  Susceptibility  to  LCM 2128  H-2D-REGULATED  RESPONSE  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
depended  upon the  LCMV-isolate and the mouse strain; e.g.  in  Fig.  2,  SWR/J 
and  ICR  were  highly  susceptible  to  both  LCMV-A-  and  -D-induced  disease, 
whereas A/J, C57BL/6, and B10.BR  were susceptible to LCMV-A, but resistant 
to -D. 
A  great variety of mouse strains were tested in many experiments for suscep- 
tibility to LCMV-A and -D as assessed by mortality and mean day of death (Table 
I).  All possible phenotypes of disease susceptibility were found: susceptibility to 
both LCMV-A and -D (Type I, e.g.  SWR/J); susceptibility to A, resistance to D 
(Type II, e.g.  B10.BR);  resistance to A, susceptibility to D  (Type III, e.g.  CBA/ 
J);  and  resistance  to  both  LCMV-A  and  -D  (Type  IV,  e.g.  DBA/2).  Thus, 
susceptibility of mice to LCM disease depended upon the virus isolate used and 
upon the general genetic background of the host. LCMV-A caused lethal disease 
TABLE  I 
Susceptibility  to LCM Disease of Various Strains of Mice Infected i.c. with ~5 ×  102 pfu of LCMV 
LCMV injected 
A  D 
Exp.  Mouse strain  Background  H-2  Phenotype 
Percent  Mean  day of  Percent  Mean day of 
mortality  death  mortality  death 
A  SWR/J  Swiss  q  100  7.5 + 0.4  100  7.0 ± 0.2  1 
BI0.G  BI0  q  100  8.2 ± 0.3  100  8,1  +  0.2  l 
C3H.Q  C3H  q  0  100  8.3 + 0.3  I11 
DBA/I  DBA  q  100  7,0 ----. 0.8  100  8.7 + 0.3  I 
A  C3H/HeJ  C3H  k  20  9  80  10.2 ~  0.4  llI 
AKR  AKR  k  100  8,1  + 0.1  100  8.2 ~  0.2  1 
BI0.BR  BI0  k  100  8.8 +  0.4  20  8  II 
CBA/J  CBA  k  40  8.5 + 0.5  100  8  Ill 
BALB.K  BALB  k  100  9  0  II 
A/J  A  k/d  100  8  20  10  II 
A2G  A  k/d  100  7.5 + 0.2  0  lI 
A  C57BL/10  BI0  b  60  9,3 + 0.6  20  10.5  lI 
BI0.BR  BI0  k  100  8.8 + 0.4  20  8  II 
BI0.G  BI0  q  100  8.2 :i= 0.3  100  8.1 + 0.2  I 
A  C3H/HeJ  C3H  k  20  9  80  10.2 + 0.4  Ill 
C3H.Q  C3H  q  0  100  8.3 + 0.3  Ill 
DBA/I  DBA  q  100  7.0 ± 0.8  100  8.7 + 0.3  I 
DBA/2  DBA  d  0  20  16  IV 
B  BALB.B  BALB  b  100  8,1  +  0.1  0  II 
BALB.K  BALB  k  100  9.0 ±  0.5  0  II 
C  (SWR  ×  DBA/2)  Swiss.×  DBA  q × d  100  9.0 ± 0.5  100  9.3 + 0.5  l 
SWR  Swiss  q  100  7.2 -+ 0.5  100  7.5 ± 0,6  I 
DBA/2  DBA  d  0  0  IV 
D  CBA/J  CBA  k  0  100  7,5 + 0.3  IlI 
D  D2.GD  DBA  d/b  0  0  IV 
DBA/2  DBA  d  0  0  IV 
(BALB/c X DBA/2)Ft  BALB ×  DBA  d  80  10.5 + 0.5  0  II 
BALB/c  BALB  d  80  8.8 :t= 0.5  0  II 
BALB.G  BALB  q  100  7,4 ± 0,3  0  II 
E  (BI0.BR × BI 0.AKM)Ft  BI0  k×k/q  100  8.5+0.2  100  8.5 + 0.3  1 
(BI0.G ×  DBA/I)FI  BI0 ×  DBA  q  90  8.7 +  1.0  95  7  I 
(BI0.BR ×  BI0.G)F1  BI0  k × q  100  8.0  100  7.5 ± 0.2  I 
7-20-wk-old mice  were injected  i.c. with 30 #1 of LCMV. Results  represent mean  values  of 5-10 mice  per group; for H-2 type see ref.  28. ZINKERNAGEL  ET  AL.  2129 
in  BALB,  most  B10,  AKR,  A,  DBA/1,  and  Swiss  mice,  but  not,  or  only 
occasionally in CBA/J, C3H/HeJ, or DBA/2 mice. LCMV-D caused lethal LCM 
in Swiss (SWR/J and ICR), AKR, most CBA/J, DBA/1, and some C3H/HeJ, but 
not in B10, BALB, A, and DBA/2 mice. In most examples studied, the genetic 
background  generally  determined  susceptibility.  In  many mouse strains  tested 
where H-2 congenic mice were available, the H-2 did not influence susceptibility 
to LCM: BALB, CBA, C3H, and most B10 mice showed identical susceptibilities 
to LCMV-A or -D, independent  of the H-2; e.g.  BALB/c (H-2d), BALB.B (H- 
2b), BALB.K (H-2k), and  BALB.G (H-2  q) all were susceptible to LCMV-A and 
resistant to -D.  However, in DBA and some B10 mice, susceptibility was influ- 
enced crucially by H-2 genes, in addition to virus and general genetic backgound. 
DBA/1 (H-2  q) were susceptible to both LCMV-A and -D, whereas DBA/2 (H-2  d) 
were resistant to both A and D. B10.G (H-2  q) mice were susceptible to LCMV- 
A and -D, whereas most other B10 H-2 congenic mouse strains were susceptible 
to A but resistant to D. 
Although H-2  q seemed to confer increased susceptibility to LCMV-D (B10.G, 
SWR/J, DBA/1 all being H-2  q and susceptible to LCMV-D) this was not always 
the  case,  since  BALB.G (H-2  q) were resistant  to  LCMV-D,  and  no  significant 
difference in susceptibility to LCM was found when C3H/HeJ (H-2  k) and C3H.Q 
(H-2  q) mice  were compared.  F1  mice  were  generally  found  to  inherit  disease 
susceptibility (Table I) e.g. (BALB/c ×  DBA/2)F~ were susceptible to LCMV-A 
but resistant  to  -D,  like  BALB/c, but  unlike  DBA]2,  which  were resistant  to 
both. Mean intervals between inoculation and death did not vary greatly. Overall, 
H-2  q mice died a little earlier (day 7-8) from LCMV-A than did other mice (day 
7.5-9). Sometimes mice infected with LCMV-D virus died a little later than those 
infected with -A, e.g. C3H/HeJ, but the reverse was also found, e.g.  (BI0.G × 
DBA/1)F~. In all examples studied, mice died of classical LCM with convulsions 
before day 11-12,  but not thereafter,  later deaths were caused by generalized 
wasting disease. 
The results obtained so far indicate clearly that susceptibility to LCM disease 
depended upon at least three parameters:  the LCMV isolate used (A vs. D), the 
general genetic background of the mice infected (Swiss mice, CBA, B10, DBA, 
etc.), and, in certain combinations tested, upon the H-2 genotype. 
Cytotoxic  T  Cell  Activity  after  i.v.  Infection  with  LCMV-A  and  -D.  Although 
somewhat controversial, many experiments (2-8) have suggested that suceptibil- 
ity to LCM correlated well with the cytotoxic T  cell activity generated in vivo. 
We tested several mouse strains representing different patterns of susceptibility 
to LCMV-A or -D. SWR/J mice were found to be highly susceptible to both A 
and D  (Fig.  2). When infected i.v. with 5  ×  10  ~ pfu of either virus strain,  they 
generated comparable cytotoxic T  cell activities on day 6, 8, or 10 (Fig. 3). Lysis 
was comparable  independent  of the  LCMV  strain  used  to  induce  the  T  cell 
response, or that used for infecting Q  (H-2  q) target cells. DBA/2 were resistant 
to  both  LCMV-A  and  -D  (Table  I),  and  failed  to  generate  significant  T  cell 
activities after infection with either virus (Table II). C57BL/6 (H-2  b) and BI0.D2 
(H-2  ~) mice were susceptible to LCMV-A and resistant to -D (Table I). B10.D2 
mice generated  measurable cytolytic activity when  infected with  LCMV-A but 
not with -D (Table II).  When C57BL/6 mice were infected i.v. with ~5  ×  102 2130  H-2D-REGULATED  RESPONSE  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
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FIGURE  3.  Two SWR/J (H-2  q) mice, 8-12 wk of age,  were infected  i.v.  with  LCMV-A  (top) 
or -D (bottom),  and  tested  individually  on  Q  (H-2  q) target  cells  infected  with  A  (0) or D (O). 
Test duration,  4  h, spontaneous  release:  Q-LCMV-A,  17%; Q-LCMV-D,  19%; uninfected Q 
targets were lysed <5%. 
TABLE  II 
LCMV-specific Cytotoxic T Cell Activity in DBA/2 and B IO.D2 Mice 
on Day 8 
Mouse strain  LCMV strain 
LU/spleen 
D2 LCMV  D2 uninfected 
B10.D2  A  800-2,000  <20 
D  <20  <20 
DBA/2  A  <20  <20 
D  <20  <20 
2-4  mice  per  group  were  injected  i.v.  with  5  x  l0  ~ pfu  of LCMV  8  d 
previously.  LU  were  measured  on  D2  targets  infected  with  LCMV-A  or 
-D,  with  comparable  results.  Test duration  was 5  b, spontaneous  release 
<17%. 
pfu of LCMV-A or -D,  the kinetics shown  in  Fig.  4  and Table  II1  were found 
for natural  killer  (NK) and  cytotoxic  T  lymphocyte  activities.  NK  activity  was 
comparable in C57BL/6  mice infected with A  and with D  (Fig. 4); it seemed to 
persist slightly longer,  albeit with  lower activity,  after infection  with LCMV-A. 
Cytotoxic T  cell activity of LCMV-A- or -D-infected  C57BL/6  mice was tested 
on MC57G (H-2 b) targets infected with A  or with D; both targets were lysed to 
comparable extents regardless of the virus isolate used for infecting target cells 
(Fig.  4).  However,  activity  rose  more  quickly,  peaked  higher,  and  persisted 
longer  in  mice  infected  with  LCMV-A  than  with  -D  (Fig.  4).  In  a  separate 
experiment,  when  LU  per  spleen  were  calculated  on  day  7  and  day  9,  the ZINKERNAGEL  ET  AL.  2131 
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FIGURE 4.  C57BL/6 mice, 7-9 wk of age, were injected i.v. with 0.2 ml containing -1,000 
pfu of LCMV-A (top) or -D (bottom). Results of two individual mice tested on MC57G (H-2  b) 
target cells infected with  LCMV-A (0) or -D (©), or on  YAC (I--l) cells.  Test duration 6  h, 
effector/target ratios: 40:1,  13:1,  4:1 ; spontaneous release for MC57G-A,  18%;  MC57G-D, 
21%; YAC,  14%.  (ll)  Indicates that no significant 5~Cr release was measured on all  targets 
tested. 
TABLE  III 
Cytolytic Activity in Spleens of C57BL/6 Mice Infected  i.v. with Various Doses of 
LCMV-A or-D 
LU (×  10 -2) per spleen at LCMV doses (pfu) of: 
LCMV  5  50  500  5,000  strain 
Day 7  Day 9  Day 7  Day 9  Day 7  Day 9  Day 7  Day 9 
A  4  230  18  110  25  180  27  30 
D  3  85  15  0.3  3  0.4  1  <0.6 
Effector cells were tested at various ratios in a  5-h 51Cr-release  assay on LCMV-A- and -D-infected 
MC57G (H-2  b) target cells; LU were determined from the dose-response  curves. Lysis of NK-sensitive 
YAC targets was < 10 LU/spleen. Spontaneous release on infected targets was 17-20%; on uninfected 
targets, 21%. 
differences became  more  obvious (Table  III).  With  5  ×  101-5  ×  l0 s  pfu  of 
LCMV-A, C57BL/6 generated 1,800-2,700 LU/spleen, vs. 300-600 LU/spleen 
after  infection  with  LCMV-D.  On  day  9,  LCMV-A-infected  C57BL/6  had 
11,000-23,000 LU/spleen, but -D-infected mice had <100 LU/spleen. With the 
highest dose of LCMV-A tested, cytotoxic T  cell activity in spleens on day 9 was 
relatively low, i.e.  3,000  LU, and  not higher  than  on day 7;  this  lower T  cell 
response is a common finding in mice infected with high doses of LCMV (4, 29). 
With low doses of LCMV-A and -D, responses were low on day 7, then responses 
with LCMV-A rose, but were only two to three times higher than for LCMV-D 
on day 9  (Table III);  this  relatively small  difference fits with the  finding that, 
with low doses of LCMV-D, some C57BL/6 died (Fig. 2). 
Cytotoxic T Lymphocyte Activity after i.c. Infection with LCMV-A vs. -D.  We tested 
representative  strains  of  mice  for  their  capacity  to  generate  LCMV-specific 
cytotoxic T  cells in spleens and leptomeningeal infiltrates after i.c. infection with 
LCMV-A or -D.  SWR/J mice, which are susceptible to both LCMV-A and  -D, 
generated  comparably  high  lytic  activity  in  meningeal  infiltrates  and  spleens 
when tested on day 6  (Table IV).  Later LU could not be tested, since all mice 
had died by day 7. C57BL/6 mice that are susceptible to LCMV-A and resistant 2132  H-2D-REGULATED  RESPONSE  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
TABLE  IV 
LCMV-specific Cytotoxic T Cell Activity in SWR/J Mice Infected i.c. 
with LCMV 
Meningeal infiltrate  Spleen 
LCMV  CSF* cells 
strain  (× 10_2)  LU*  LU (× 10  -2) 
Day 5  Day 6  Day 5  Day 6  Day 5  Day 6 
A  30  110  <1  52  2  150 ~ 
D  35  120  <1  30  12  110 
Mice were injected i.c. with  103 pfu of LCMV;  all mice injected 7 d 
previously died. 
* Cerebrospinal  fluid  (CSF)  was  taken  and  cells per  microliter were 
counted. 
* Test duration 6 h, spontaneous release from LCMV-D-infected (H-2 q) 
target ceils was 21%; <1  LU/spleen was found on uninfected targets. 
Effector cells from day 6 were also tested on LCMV-A-infected target 
cells (20%  spontaneous release) with  140  vs. 95  LU for LCMV-A vs. 
LCMV-D immune spleen cells. 
TABLE  V 
Cytolytic T Cell Activity in C57BL/6 Mice Infected i.c. with LCMV-A or -D 
LU (x 10 -2) per spleen on day: 
Virus dose  5  6  7  8  (pfu) 
A  D  A  D  A  D  A  D 
2,000  <l  2  24  6  55  26  45  8 
200  <!  <!  16  7  ll5  18  37  16 
20  <1  <1  9  6  12  8  40  55 
LU per meningealinfiltrate: 
2,000  <1  <1  30  1  250  40  270  30 
200  <l  <1  10  3  270  20  280  250 
20  <1  <1  3  1  30  4  80  ND 
Mice were injected with 30 #l containing various amounts of LCMV. Cytotoxicity was assessed in a 
5-h test with various effector/target cell ratios, and LU were calculated from dose-response curves. 
Spontaneous release on (MC57G-LCMV-D)  infected target cells was 25%. ND, not determined. 
to -D were injected with  various doses of A  or D  i.c., and their spleen cells and 
meningeal infiltrate cells were assayed for cytotoxic T  cell activity on  day 5,  6, 
7, and 8  (Table V). Clearly, LU per meningeal infiltrates were higher in LCMV- 
A-injected mice on all days tested, with  differences being particularly great on 
days 6  and  7; diminishing on  day 8.  The  same trend  was seen in spleens of the 
same mice, but with smaller differences than found for meningeal infiltrate cells. 
When a  lower infectious dose of 20 pfu was used, lytic activity (LU) in meningeal 
infiltrates and spleens of D-infected mice increased quite considerably on day 8, 
and mice did occasionally die of these doses (see Fig. 2). 
H-2D-linked  Susceptibility  to  LCMV-D  in  BIO  Mice.  H-2  congenic  B10  mice 
show consistent susceptibility to LCMV-A  (Table I).  As shown  in a  preliminary 
report  (22),  we confirmed  here that  B10  mice possessing the  H-2D q allele were 
susceptible to LCMV-D  (Table VI). C57BL/10  (H-2K  b,  I b,  Db), B10.BR  (K  k, I k, ZINKERNAGEL  ET  AL.  2133 
TABLE  VI 
H-2q-linked Susceptibility to LCMV-A vs. -D in B IO Background Mice 
Percent 
Strain  Haplotype  mortality  Mean day of death 
H-2KID 
A  D  A  D 
B10.MBR  bkq  100  100  7.0  8.1 -F 0,9 
B10.BR  kkk  100  0  7.9 +  0.1  Survived* 
B6.AK1  bbk  100  0  8.0  Survived 
C57BL/10  bbb  100  0  8.1 -  0.3  Survived 
B10.G  qqq  100  100  8.2 +- 0.4  8.0 _+ 0.4 
5-10 mice were injected i.c.  with 30 ttl containing l0  s pfu of LCMV-A 
or -D. 
* Observation period, 20 d. 
TABLE  VII 
Dose Dependence of Primary Footpad Swelling Caused by LCMV-A 
and -D on Day 7 Postinfection 
Mouse strain  Virus strain 
Percent specific increase of footpad 
thickness in mice given doses (pfu) of: 
50  500  5,000 
SWR/J  A  125  100  105 
SWR/J  D  105  115  80 
C57BL/6  A  <5  110  100 
C57BL/6  D  <5  20  <5 
Average of measurements of 4-8 footpads; SEM <10%. 
120 ]  C57Bt./6  ~  SWR/J  DBA/2 
ioo 1 
=~"°I  //  k\ 
2  4  6  8  10  12  14  2  4  6  8  10  12  14  2  4  6  8  10  12  14 
TIME AFTER INJECTION INTO FOOTPAD (DAYS) 
FIGURE 5.  Mice were  injected with  103  pfu  of LCMV-A  (0) or  -D  (O)  into the footpad. 
Footpad  thickness was  measured  daily  thereafter  and  compared  with preinjection values. 
Values are means of measurements of 6-8 footpads; SEM <10% of the values indicated for 
SWR/J and C57BL]6, and are not shown. Range of values varied greatly for DBA/2 mice, 
and therefore are shown. 
Dk), and  B6.AK1  (K  b,  I b,  D  k)  were all  resistent  to  l0 s  pfu  of LCMV-D  i.c., 
whereas B 10.MBR (K  b,  I k,  O q) and B 10.G (K  q, I q, D q) were  susceptible, thereby 
mapping susceptibility to LCMV-D to H-2D  q. 
Primary Footpad Swelling Reaction after Local Infection with LCMV-A vs. -D.  The 
primary footpad swelling reaction after local infection with LCMV is strictly T 
ceil-dependent (15,  26,  27).  In  SWR/J  mice,  which are  susceptible  to  both 
LCMV-A and -D, the kinetics of the local footpad response to  5  x  102 pfu of 
LCMV-A or -D was virtually identical (Table VII and Fig. 5). In C57BL/6 mice, 2134  H-2D-REGULATED  RESPONSE  TO  LYMPHOCYTIC  CHORIOMENINGITtS 
which are susceptible to LCMV-A and resistant to -D, the footpad reaction to A 
increased rapidly from 0-110% swelling between day 6 and day 7, but D-infected 
mice  showed  much  lower and  slower responses  (Fig.  5).  The  comparable  re- 
sponses in  A- or D-infected SWR/J, and the differential responses in C57BL/6 
mice were seen over a wide range of infectious doses (Table VII). The response 
to  small  doses (50  pfu)  in  C57BL/6  only  became  measurable  on  day  8  after 
infection,  and  then  showed values of 80%  swelling for A  vs.  10%  for  D  (not 
shown).  In  both strains  of mice,  footpad swelling declined a  little slower in  D- 
than in A-infected mice (Fig. 5). 
DBA/2 mice, which were resistant to both LCMV isolates, developed virtually 
no or only variable primary footpad swelling upon infection with 5 x  102 pfu of 
either A or D (Fig. 5). 
Footpad Swelling Reaction Is Regulated by H-2D.  After local infection into the 
footpad with LCMV-A vs. -D, early footpad swelling was measured on day 6 in 
various H-2 congenic mouse strains.  Pronounced  differences were seen, which 
correlated with susceptibility to LCM after i.c. inoculation (Table VIII). Footpad 
measurements  on  day  8  and  day  9  revealed  smaller  differences  (see  Fig.  5, 
C57BL/6). When  B10 congenic mice were injected simultaneously i.c. and i.f., 
the following results were obtained: all B ! 0 mice showed rapid and early footpad 
swelling after infection  with  LCMV-A, and all  mice died of LCM by day 8-9. 
The same mice showed a differential response after i.c.  and local infection into 
the footpad with LCMV-D (Fig.  6).  Whereas B10.G (K  q,  I q,  D q) and B10.AKM 
(K  k,  I k,  D q) mice showed a  rapid  and  high  response,  B10.A  (K  k,  I k/d, D a) and 
B10.BR (K  k,  I k,  D k) mice showed variably lower and  slower responses.  B10.G 
(K q,  1  q,  O q) and B10.AKM (K  k, I k, O q) died on days 8 and 9; B10.A (K  k, I k/d, D d) 
TABLE VIII 
Primary Footpad Swelling on Day 6 vs. Lethal LCM 
Immunopathology 
Percent in- 
crease of  Positive of  Percent  Mouse strain  LCMV  footpad  total mice  mortality 
(H-2)  strain  thickness  injected*  of LCM* 
on day 6* 
DBA/1 (q)§  A  70 +  5  5/5  100 
D  21  +  4  4/5  100 
DBA/2 (d)  A  5  0/5  0 
D  5  0/5  0 
B10.G (q)  A  60 +  3  5/5  100 
D  49 _.+ 6  5/5  100 
B10.BR (k)  A  43  +  8  5/5  100 
D  8 +  5  2/5  0 
* Mice were injected i.f.  with 1,000 pfu of LCMV. 
* Mice were injected i.c. with 1,000 pfu of LCMV. 
§ 3-5 mice were injected into one footpad; swelling was compared with 
the uninfected footpad. ZINKERNAGEL  ET  AL.  2135 
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FIGURE  6.  Various B10 congenic mice were simultaneously injected with 1,000 pfu i.c. and 
i.f. of LCMV-D. Percent increase of footpad thickness was measured daily. The values indicate 
the averages of 6-8 footpads; the ranges are also shown. 
and B10.BR (K  k, I k, D k) mice survived. Since B10.AKM differ genetically from 
B10.BR mice only in the H-2D region, both susceptibility to LCMV-D and the 
capacity to mount a rapid and high footpad swelling reaction were shown to be 
regulated by H-2D;  Dq conferring high responsiveness, and D k causing lower 
responsiveness. 
Discussion 
Two plaque variants of LCMV isolated from a carrier mouse (20, 21) showed 
the  following  characteristics  in  vivo:  depending  upon  both  the  virus  isolate 
injected i.c. and the strain of mice tested, the susceptibility to LCM disease varied 
greatly, most drastically with non-H-2 background genes.  Four phenotypes of 
disease susceptibility patterns were found in young adult mice (6-20 wk): suscep- 
tibility  to  both,  resistance  to  both,  susceptibility  to  one  LCMV  isolate  and 
resistance  to  the  other,  and  vice versa.  However,  in  certain  combinations of 
mouse strain  and  LCMV  isolate,  a  dominant regulatory role  of H-2  became 
apparent. As reported elsewhere (22) and documented here with DBA mice and 
additional B 10 H-2-recombinant mouse strains, susceptibility to LCMV-D could 
be  shown,  in  a  few examples,  to  be crucially regulated by H-2,  in  B10  mice 
particularly by H-2D. These results are compatible with those from recent studies 
(30) with BALB/c and D dm mutant mice, which showed that mice carrying the 
D dm2 mutations were less susceptible to the LCMV-Armstrong isolate; only 50% 
of i.c.-infected O din2 mice died, as compared to  100%  for BALB/c, which have 
the wild type D d. 
All three parameters studied here, i.e. susceptibility to LCM, cytolytic T  cell 
activity (22), and primary footpad swelling are shown to be regulated by H-2D. 
This correlation  indica.tes that  both  cytolytic activity in  vitro (and possibly in 
vivo) and  recruitment of inflammatory cells  is  mediated by  the  same  T  cell 
subpopulation, restricted predominantly to class I H-2D-coded antigens (4). This 
may settle the dispute as to whether delayed-type hypersensitivity mechanisms 
(11-13) rather than cytotoxic T  cells are responsible for LCM disease (7-10); it 
appears likely that the same effector T  cells are responsible for both phenomena. 
This and earlier results (15,  16) also indicate that delayed-type hypersensitivity 2136  H-2D-REGULATED  RESPONSE  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
can be induced  by MHC class I- or class II-restricted  T  cells (24);  since both 
types of T  cells release various lymphokines involved in recruitment  of inflam- 
matory cells, this finding is not unexpected. In general, antigens that actively (or 
by fusion) induce new antigenic  determinants  on cell surfaces (such as viruses) 
induce T  cells (including those mediating delayed-type hypersensitivity) that are 
restricted  to class  I  or class  II  MHC products;  antigens  that  become passively 
associated with cell surfaces (such as antigens of intracellular bacteria or soluble 
antigens) trigger T  cells specific for class II MHC products (24). 
Non-MHC  background  genes  influenced  susceptibility  to  LCM  drastically. 
Outbred  ICR  and  SWR/J  (Swiss)  mice  were,  in  general,  susceptible  to  both 
LCMV isolates.  BALB, C57BL, and  A  mice were susceptible to LCMV-A and 
resistant  to -D;  C3H/HeJ and  CBA/J  mice tested  were more susceptible to  D 
than  to A.  Differences in  susceptibility to LCM or in  the capacities of various 
strains to generate cytotoxic T  cells have been noticed previously: outbred Swiss 
mice or inbred mice derived from them have repeatedly been found (31-33) to 
be  highly  susceptible to  LCM.  DBA/2  mice  have  been  shown  (34)  to  be  low 
responders to LCMV-WE. DBA/1 and C57BL/6 mice were found (31, 33) to be 
high responders to LCMV-WE, while AKR and CBA/J were shown (31-33) to 
be  low responders  when  tested  for  their  cytotoxic T  cell  activities as  well as 
primary footpad reaction. 
The results obtained with C3H/HeJ mice differ from published data (14, 21). 
Pfau et al. routinely used C3HeB/FeJ mice 3-4 wk of age, and found that these 
mice were clearly susceptible to  LCMV-A and  resistant  to -D.  Since C3H and 
CBA mice bred in different laboratories vary greatly (35), these results may be 
a  reflection of such genetic differences (33).  Our data show a  very clear corre- 
lation  between susceptibility to  LCM and  the  capacity to  mount  an  early and 
high  LCMV-specific  cytotoxic T  cell  response.  In  C57BL/6  mice,  which  are 
susceptible to  LCMV-A,  i.c.  or  i.v.  infection  with  this  LCMV  isolate  induced 
high cytolytic activities in meningeal  infiltrates and spleen; in contrast,  LCMV- 
D  caused no or only occasional deaths, and induced 5-10 times lower cytolytic 
activities, which rose more slowly (Tables III and V, and Fig. 4). If infected with 
relatively low doses of LCMV-D,  C57BL/6 mice generated  considerable levels 
of cytotoxic T  cells, and occasionally died of LCM (see also Fig.  2).  This result 
is compatible with the explanation  that LCM disease develops only if effector T 
ceils are  recruited  preferentially  to the  brain.  Since  LCMV-D replicates more 
rapidly than  LCMV-A (21), -D usually spreads widely, and effector cells may be 
diverted to sites other than the brain, inducing systemic nonlethal disease (2, 4, 
21, 29, 36-39).  However, with a small dose of LCMV-D, the brain remains the 
main target organ and the disease may be lethal. Both the relatively short interval 
during which lethal LCM may develop (i.e.  dependent upon mouse strain during 
a  2-3-d  interval  starting  on  day 6-8),  and  the  virus dose dependence  (2,  36) 
show that lethal LCM is the result of a delicate balance between virus localization 
and  spread,  and  immune  T  cell  response  (36-39).  This  complex  biological 
equilibrium  resulting  in  susceptibility or  resistance  to  lethal  LCM disease can 
therefore  not  be  an  all-or-none  difference  with  respect  to  cytotoxic  T  cell 
activities or primary footpad swelling; 5-10-fold differences in relative cytotoxic 
activities and  1-2-d differences in the respective kinetics are apparently respon- Z1NKERNAGEL ET  AL.  2137 
sible for great differences in susceptibility to LCM disease. Studying C3HeB/FeJ 
mice on day 8 after i.c. infection with -500 pfu of LCMV-A or -D, Pfau et al. 
(14) found  no correlation  between susceptibility to  LCM and  cytotoxic T  cell 
activity found in spleens or meningeal infiltrates. As documented here, monitor- 
ing  a  single  timepoint  may  not  reveal  the  differing  kinetics  of the  antiviral 
response that, herein, correlated clearly with susceptibility. In fact, an infectious 
dose of LCMV-A and -D comparable to the one used by Pfau et al. (2 x  102 pfu) 
initiated generation of equal activities of cytotoxic T  cells in C57BL/6 mice when 
tested  on  day  8  (Table  V);  however  they  differed  vastly  on  days  6  and  7. 
Therefore, it is to be expected that the cytotoxic T  cell response of C3HeB/FeJ 
mice will correlate with susceptibility to LCM when tested with various LCMV 
doses over several days. 
MHC association of LCM disease susceptibility has first been documented by 
Oldstone et al. (32); however, these findings have not been confirmed (40, 41). 
Our previous report (22) and this study of LCMV-D in B10 mice, as well as the 
results obtained with mutant D am mice and LCMV-Armstrong (30), show suscep- 
tibility as mapping to H-2D. The reported (40, 41) difficulties to confirm  H-2- 
dependence of LCM susceptibility in C3H mice may be due to many experimental 
variables such as  genetic  variation  (35),  age of mice,  and  substrain  of LCMV 
used. In addition, the possibility that the health status of experimental mice may 
influence susceptibility to LCM must be further evaluated. 
The  observed differences in  susceptibilities to  LCM are difficult to explain. 
Obviously, the  A  vs.  D  pattern  depends upon both  LCMV isolate and  mouse 
strain.  Since  all  possible  susceptibility  patterns  have  been  observed,  no  easy 
explanation  can  be  given.  Differences  in  virus  replication  (21)  and  spread, 
organtropism  (2,  3),  o~, /3, or 3' interferon  induction  and/or  susceptibility to it, 
(30,  42-44),  as well as differences in antigenicity  and/or  immunogenicity  (22, 
30, 45-47)  may all  be invoked to explain  the findings.  As pointed out above, 
differential  LCMV replications and spreads correlate with  LCM disease (2,  21, 
37). The rapid replication and wide spread of the virus generally correlated with 
D,  whereas  slow  and  restricted  growth  characterized  the  A  pattern.  These 
parameters are currently being studied for the mouse strains studied here; but 
in B 10 mice the above general rule that LCM-D replicates faster than LCMV-A 
has been confirmed in a preliminary experiment. Published results on interferon 
levels in  LCMV infections do not allow any conclusion as to the respective role 
of ~,  /~,  or  3"  interferon  in  causing  the  D  or  A  pattern  (43).  Although  not 
serologically  distinguished  so  far,  LCMV  isolates  may  differ  with  respect  to 
antigens defined by monocional antibodies as shown for rabies virus (45) and/or 
recognized  by  T  cells.  Ahmed  et  al.  (46)  and  Byrne  et  al.  (47)  have  found 
differences among  various  LCMV  strains  when  assayed  for  their  capacity  to 
serve, on infected cells, as target antigens for cytotoxic T  cells. These differences 
may cause induction of differing T  cell responses mainly dependent upon MHC 
Ir  genes.  Such  possible  antigenic  differences  are  now  being  searched  for  in 
LCMV-A and -D; they could readily explain why, in B10 mice, H-2D influences 
susceptibility to D but not to A. A surprising conclusion is that complex antigens 
such  as  viruses  appear  to  induce  only  very  few,  or  most  probably  only  one 
antigen(s) or antigenic site(s) recognized by biologically relevant effector T  cells, 2138  H-2D-REGULATED  RESPONSE TO  LYMPHOCYTIC CHORIOMENINGITIS 
otherwise  MHC  regulation  of an  antiviral  T  cell  immune  response  could  not 
become so obviously limiting. 
In  conclusion,  LCMV-induced  disease  is  a  model  in  mice  exhibiting  clear 
susceptibility differences varying with virus isolate, general genetic background, 
and  major  transplantation  antigens  of the  host.  MHC disease associations are 
recognized  only when  a  particular  virus  isolate infects  the appropriate  mouse 
strain.  In  many  respects,  this  model  reflects  the  situation  found  in  outbred 
humans (48, 49). MHC disease associations are relatively weak and variable. This 
may probably be  due  to:  (a)  the  possibility that  known  or  unknown  non-  or 
poorly cytopathic infectious agents that  seem to be serologically identical  may 
differ antigenically as seen by T  cells; (b) many important non-HLA genes vary 
throughout  the  population  and  amongst  different  races,  and  (c)  serologically 
defined HLA types may actually comprise several variant  HLA molecules (24, 
50-52). In this study, inbred mice and cloned virus isolates reduce these numer- 
ous variables to show that,  under well-defined conditions,  MHC disease associa- 
tion  is  very  strong  and  may  directly  reveal  MHC-regulated  T  cell-mediated 
immunopathology. 
Summary 
The lymphocytic choriomeningitis  virus (LCMV) isolates Docile (D) and Ag- 
gressive (A) of Pfau et al.  (21) were studied in various strains  of mice.  Disease 
susceptibility, assessed as mortality and time to death  to LCMV-D or -A varied 
greatly amongst mouse strains,  and all four possible susceptibility patterns were 
observed: susceptiblity to  both  (e.g.  SWR/J),  resistance  to  both (e.g.  DBA/2), 
susceptibility to A  but resistance  to D  (C57BL/6),  or vice versa (CBA/J).  Irre- 
spective of the virus isolate or the mouse strain  tested, susceptibility correlated 
with both early and high cytotoxic T  cell activity found in spleens or leptomen- 
ingeal infiltrates, and with early and high primary footpad swelling reaction after 
local infection. C57BL/6 mice infected with A or SWR/J infected with A or with 
D  showed,  in  both  test  systems, early and  high  activities;  in  contrast,  DBA/2 
mice infected with either D or A, and C57BL/6 infected with D  showed no or 
only slow and low responses in both tests. Early and high LCMV-specific cytotoxic 
T  cell  activity,  and  the  rapidity  and  extent  of the  primary  footpad  reaction 
directly correlated with susceptibility to LCM and all were dominantly regulated 
by H-2D. 
We  thank  C.  Pfau  for  generously  donating  LCMV-A  and  -D  virus,  and  for  many 
discussions; R. Joho and H.-P. Pircher for critically reading the manuscript,  and B. Borter 
and R. Caprez for excellent secretarial  assistance. 
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